She had the door open before he even knocked. She was watching for him." Daniel was between meetings on the 15th floor of his own building. He stepped out into the stairwell and closed the door. "Plate number?" he asked.
Isaiah read off a partial. It matched, through a contact at a security firm, to a vehicle registered to a private consulting company in a commercial district across the city. The company name pulled up no public record of significance. But when Daniel ran it through his own business network, a favor from a former colleague who specialized in corporate intelligence. One connection surfaced.
A biotech firm called Veridian Solutions, which had approached Daniel's investment office 18 months ago seeking backing for experimental neurological enhancement research. He had declined the meeting himself. The pitch had been interesting in the way that ethically unsettled ideas are always somewhat interesting, and he had passed on it within a week. He remembered the name of the scientist who had presented. He had thought at the time that the man was either brilliant or dangerous, and that those two qualities were not as mutually exclusive as comfortable people assumed.
He pulled the original pitch document from his archived files that evening, uh reading it properly for the first time since the meeting 18 months ago. The research outline described a process of controlled sensory disruption followed by neurological recalibration, suppressing one processing pathway in order to force the brain to develop compensatory mechanisms with the theoretical outcome being enhanced multi-sensory capacity. The document was dense with research jargon, but the core claim was stark. You could temporarily impair a child's vision, and through that process train the brain to process sensory data with a precision beyond normal human capacity. It had struck Daniel at the time as something between ambitious and reckless.
He had passed on the investment without losing sleep over it. Now he understood that someone else had agreed to fund it, and whoever that someone was, they had needed a subject. And Evelyn, for reasons Daniel had not yet fully mapped, had provided one. He looked at the name he had written, Dr. Halverson. He wrote it again beneath the name of the company, and beneath that he wrote Evelyn's name, and he looked at the triangle on the page and understood for the first time that he was not dealing with a wife who had made a terrible, isolated decision.
He was dealing with a coordinated operation that had used his home as a laboratory and his daughter as a subject. The controlled test was Isaiah's idea, delivered the way all of his ideas arrived, without preamble, as if the answer had simply been sitting there waiting for someone practical enough to say it. "Take Lily somewhere for a couple days," he said during their evening call. "Somewhere your wife can't reach the food. Have your doctor run it as a checkup.